Leerink Partnrs Has Pessimistic View of THC Q2 Earnings

Tenet Healthcare Co. (NYSE:THC) – Stock analysts at Leerink Partnrs reduced their Q2 2025 earnings estimates for shares of Tenet Healthcare in a research note issued on Wednesday, February 12th. Leerink Partnrs analyst W. Mayo now expects that the company will earn $2.60 per share for the quarter, down from their prior estimate of $2.66. The consensus estimate for Tenet Healthcare’s current full-year earnings is $11.37 per share. Leerink Partnrs also issued estimates for Tenet Healthcare’s Q4 2025 earnings at $3.43 EPS, Q1 2026 earnings at $3.46 EPS, Q2 2026 earnings at $3.27 EPS, Q3 2026 earnings at $3.08 EPS, Q4 2026 earnings at $3.83 EPS, FY2028 earnings at $25.45 EPS and FY2029 earnings at $28.57 EPS.

THC has been the subject of several other research reports. Wells Fargo & Company cut Tenet Healthcare from an “overweight” rating to an “equal weight” rating and lowered their price target for the company from $205.00 to $150.00 in a report on Monday, November 25th. StockNews.com downgraded shares of Tenet Healthcare from a “buy” rating to a “hold” rating in a research note on Thursday. Barclays lowered their price objective on shares of Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating for the company in a research note on Thursday. UBS Group lifted their target price on Tenet Healthcare from $197.00 to $217.00 and gave the company a “buy” rating in a report on Wednesday, October 30th. Finally, Raymond James lowered Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price target for the company. in a research note on Friday, November 22nd. Four analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $163.19.

Tenet Healthcare Price Performance

Shares of NYSE:THC opened at $133.02 on Friday. The business has a fifty day simple moving average of $133.43 and a 200-day simple moving average of $148.26. Tenet Healthcare has a 52 week low of $87.06 and a 52 week high of $171.20. The company has a market cap of $12.65 billion, a P/E ratio of 4.26, a P/E/G ratio of 0.63 and a beta of 2.05. The company has a quick ratio of 1.52, a current ratio of 1.58 and a debt-to-equity ratio of 2.35.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 14.91% and a return on equity of 24.05%.

Institutional Trading of Tenet Healthcare

Several large investors have recently bought and sold shares of the company. New Wave Wealth Advisors LLC acquired a new position in Tenet Healthcare in the 4th quarter worth $343,000. Swedbank AB raised its position in shares of Tenet Healthcare by 100.0% in the 4th quarter. Swedbank AB now owns 40,000 shares of the company’s stock valued at $5,049,000 after purchasing an additional 20,000 shares in the last quarter. Legacy Capital Group California Inc. acquired a new stake in shares of Tenet Healthcare during the third quarter worth approximately $1,055,000. Signet Financial Management LLC acquired a new stake in Tenet Healthcare in the fourth quarter valued at $1,526,000. Finally, China Universal Asset Management Co. Ltd. bought a new position in Tenet Healthcare during the 4th quarter valued at $410,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.